Malaria is still one of the most important tropical diseases, killing millions every year. The number of effective drugs is limited, because of the ability of the causative parasite Plasmodium falciparum to develop drug resistance. Mefloquine, if possible in combination with an artemisinin derivative, is the only efficacious treatment left for uncomplicated but highly multidrug-resistant P. falciparum infections encountered in some areas. Mefloquine remains effective in most endemic areas worldwide for both prophylaxis and treatment of malaria. Generally, mefloquine is well tolerated but it is associated occasionally with neuropsychiatric adverse effects, whether used as treatment or for prophylaxis. In recent years, mefloquine has acquired...
Mefloquine (a marketed anti-malaria drug) prophylaxis has a high risk of causing adverse events. Int...
Abstract Background Mefloquine-artesunate combination therapy for uncomplicated falciparum malaria i...
textabstractAims: We performed a prospective cohort study to gain more insight into risk factors for...
The Australian Defence Force (ADF) has used mefloquine for malaria chemoprophylaxis since 1990. Mefl...
Case reports and epidemiological studies have associated the use of mefloquine with neuropsychiatric...
Introduction: Mefloquine (MQ) is a synthetic quinoline derivative antimalarial drug that is structur...
Mefloquine (MQ) has been used for the treatment of malaria since the mid-1980s, first as monotherapy...
Various drugs are widely used in the prophylaxis and treatment of malaria. In the prevention of mala...
Mefloquine (MQ) has been used for the treatment of malaria since the mid-1980s, first as monotherapy...
Background Antimalarial drugs affect the central nervous system, but it is difficult to differentiat...
This is a small case study on the appropriateness of mefloquine in a patient with a co-existing psyc...
Abstract Background Malaria chemoprophylaxis prevents the occurrence of the symptoms of malaria. Tra...
AbstractMefloquine is a quinoline derivative antimalarial which demonstrates promise for the treatme...
Currently available medications for malaria chemoprophylaxis are efficacious but the problems of pat...
Malaria, caused mostly by Plasmodium falciparum and P. vivax, remains one of the most important infe...
Mefloquine (a marketed anti-malaria drug) prophylaxis has a high risk of causing adverse events. Int...
Abstract Background Mefloquine-artesunate combination therapy for uncomplicated falciparum malaria i...
textabstractAims: We performed a prospective cohort study to gain more insight into risk factors for...
The Australian Defence Force (ADF) has used mefloquine for malaria chemoprophylaxis since 1990. Mefl...
Case reports and epidemiological studies have associated the use of mefloquine with neuropsychiatric...
Introduction: Mefloquine (MQ) is a synthetic quinoline derivative antimalarial drug that is structur...
Mefloquine (MQ) has been used for the treatment of malaria since the mid-1980s, first as monotherapy...
Various drugs are widely used in the prophylaxis and treatment of malaria. In the prevention of mala...
Mefloquine (MQ) has been used for the treatment of malaria since the mid-1980s, first as monotherapy...
Background Antimalarial drugs affect the central nervous system, but it is difficult to differentiat...
This is a small case study on the appropriateness of mefloquine in a patient with a co-existing psyc...
Abstract Background Malaria chemoprophylaxis prevents the occurrence of the symptoms of malaria. Tra...
AbstractMefloquine is a quinoline derivative antimalarial which demonstrates promise for the treatme...
Currently available medications for malaria chemoprophylaxis are efficacious but the problems of pat...
Malaria, caused mostly by Plasmodium falciparum and P. vivax, remains one of the most important infe...
Mefloquine (a marketed anti-malaria drug) prophylaxis has a high risk of causing adverse events. Int...
Abstract Background Mefloquine-artesunate combination therapy for uncomplicated falciparum malaria i...
textabstractAims: We performed a prospective cohort study to gain more insight into risk factors for...